Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eunjeong Shin
Institutions:
Louis Stokes Cleveland VA Medical Center,
Case Western Reserve University
Observed institutions:
Veterans Health Administration,
University of Florida,
Kyung Hee University,
Louis Stokes Cleveland VA Medical Center,
Case Western Reserve University
ORCID:
0009-0006-2472-3264
Observed ORCID:
0009-0006-2472-3264
OpenAlex ID:
A5008345574
A microbiological and structural analysis of the interplay between sulbactam/durlobactam and imipenem against penicillin-binding proteins (PBPs) of Acinetobacter spp.
2025
·
Balaji Veeraraghavan
, Eunjeong Shin
, et al.
·
Antimicrobial Agents and Chemotherapy
·
38
First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus
2020
·
Alaa R. M. Sayed
, Nirav R. Shah
, et al.
·
Antimicrobial Agents and Chemotherapy
·
33
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation
2024
·
Jieqiang Zhou
, Yuli Qian
, et al.
·
Antimicrobial Agents and Chemotherapy
·
25
PDF
Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Mycobacterium abscessus
2024
·
Khalid M. Dousa
, Eunjeong Shin
, et al.
·
mBio
·
21
Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics
2024
·
Eunjeong Shin
, Yongzhen Zhang
, et al.
·
Antimicrobial Agents and Chemotherapy
·
17
PDF
Durlobactam in combination with β-lactams to combat Mycobacterium abscessus
2024
·
Eunjeong Shin
, Khalid M. Dousa
, et al.
·
Antimicrobial Agents and Chemotherapy
·
15
Combating Multidrug‐Resistant Bacteria by Integrating a Novel Target Site Penetration and Receptor Binding Assay Platform Into Translational Modeling
2021
·
Yinzhi Lang
, Nirav R. Shah
, et al.
·
Clinical Pharmacology & Therapeutics
·
14
PDF
The Role of β-Lactam Antibiotics in Treating Mycobacterium abscessus : From Laboratory Insights to Clinical Applications and the Case for Clinical Trials
2025
·
Khalid M Dousa
, Eunjeong Shin
, et al.
·
Clinical Infectious Diseases
·
9
PDF
Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of Mycobacterium tuberculosis
2024
·
Mary Nantongo
, David C. Nguyen
, et al.
·
ACS Infectious Diseases
·
8
Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947–2019
2022
·
Jordan L Kennedy
, Jürgen B Bulitta
, et al.
·
Clinical Infectious Diseases
·
7
Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics
2019
·
Jürgen B. Bulitta
, Yuanyuan Jiao
, et al.
·
Pharmaceutics
·
6
PDF
Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard Inocula
2023
·
Jürgen B. Bulitta
, Eunjeong Shin
, et al.
·
Journal of Pharmaceutical Sciences
·
4
Exploring β-lactam interactions with DacB1: unraveling optimal therapies for combating drug-resistant Mycobacterium tuberculosis
2025
·
Mary Nantongo
, David C. Nguyen
, et al.
·
mBio
·
2
P-1503. Dual β-Lactam Approach for Treatment of Mycobacterium abscessus Infections in Adults – Results in 19 Patients
2025
·
Gautam Kalyatanda
, Khalid M Dousa
, et al.
·
Open Forum Infectious Diseases
·
2
Deproteinization with ZnSO4–Ba(OH)2reduces the photodegradation of montelukast during plasma sample preparation for HPLC analysis
2016
·
Eunjeong Shin
, Ju-Hee Oh
, et al.
·
Journal of Liquid Chromatography & Related Technologies
·
2
Novel C5α-substituted carbapenems enhance Mycobacterium abscessus killing via selective target binding and reduced hydrolysis by Bla Mab
2025
·
Eunjeong Shin
, Magdalena A. Taracila
, et al.
·
Antimicrobial Agents and Chemotherapy
·
1
Abstract 2394 Optimizing Carbapenem Side-Chain Geometry to Enhance Activity Against Mycobacterium tuberculosis
2026
·
Mary Nantongo
, David Nguyen
, et al.
·
Journal of Biological Chemistry
Synergistic activity of dual β-lactams against Mycobacterium avium complex
2026
·
Eunjeong Shin
, Khalid M. Dousa
, et al.
·
Microbiology Spectrum
Abstract 2610 Modified Carbapenem Derivatives exhibit Potential Inhibition against Mycobacterium tuberculosis Peptidoglycan Synthesis
2025
·
Mary Nantongo
, David Nguyen
, et al.
·
Journal of Biological Chemistry
PDF
P-788. Exploring β-Lactam Interactions with DacB1: Unraveling Optimal Therapies for Combating Drug-Resistant Mycobacterium tuberculosis
2025
·
Mary Nantongo
, David C Nguyen
, et al.
·
Open Forum Infectious Diseases
P-775. Unlocking Synergistic Potency: Dual Action of β-Lactam and β-Lactamase Inhibitor in Combating Mycobacterium abscessus through β-Lactamase Inhibition and Multi-Target Receptor Inactivation
2025
·
Eunjeong Shin
, Khalid M Dousa
, et al.
·
Open Forum Infectious Diseases
2806. The Mechanism of β-Lactam Antibiotic Action: Structural Analysis of Mycobacterium abscessus l,d-Transpeptidases, d,d-Carboxypeptidase and penicillin-binding-proteins binding by imipenem, ceftaroline, and amoxicillin
2023
·
Eunjeong Shin
, Mary Nantongo
, et al.
·
Open Forum Infectious Diseases
PDF
2565. In vitro synergistic bacterial killing of imipenem and ceftaroline against Mycobacterium abscessus; a static concentration time-kill analysis
2023
·
Eunjeong Shin
, Mary Nantongo
, et al.
·
Open Forum Infectious Diseases
PDF
Show more works
View as search
Works count:
23
Citation count:
213
H-index:
8
I10-index:
7
Year
Topic
Type